Cargando…
Contemporary Monoclonal Antibody Utilization in Glomerular Diseases
Therapeutic monoclonal antibodies (MAbs) have been one of the fastest growing drug classes in the past 2 decades and are indicated in the treatment of cancer, autoimmune disorders, solid organ transplantation, and glomerular diseases. The Food and Drug Administration has approved 100 MAbs between 19...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338194/ https://www.ncbi.nlm.nih.gov/pubmed/37448529 http://dx.doi.org/10.1016/j.mayocpiqo.2023.04.009 |